One of the lecture halls at the Chemistry Department of Moscow State University has been completely renovated and re-equipped using funding provided by URALCHEM.
Moscow, Russia (April 29, 2013) — One of the lecture halls at the Chemistry Department of Moscow State University has been completely renovated and re-equipped using funding provided by URALCHEM.
URALCHEM was responsible for both the financing and organization of all phases of the work, which ranged from architectural design and major repairs to the purchase of computer equipment and furniture. Repair work began in October 2012 and is now completed. Today, the renovated hall is a comfortable auditorium, seating 35 students and containing the latest laboratory equipment, computers, office and video conferencing facilities. The project costs were 5.2 million roubles.
URALCHEM and Moscow State University have been collaborating since 2011, since when the Department of Chemistry has set up special training programmes for the company’s employees. The training curriculum includes a 72-hour course for workers without any previous educational background in chemistry (“Chemistry for non-chemists”), and a 105-hour course for those who already hold college and university degrees in chemistry (“Chemical technology of inorganic substances”).
Dmitry Konyaev, CEO of URALCHEM commented, “We attach great importance to our cooperation with the Chemistry Department of Moscow State University. It is the leading university in the country and whose graduates are sought after in many sectors of the economy. The quality of its education remains at a consistently high level. I am therefore pleased that our partnership is developing and I hope that our support will facilitate the maintenance of its high educational standards.”
URALCHEM’s director of Human Resources, Svetlana Chekalova said, “I would like to thank the administration and staff of the Chemistry Department of Moscow State University for its cooperation. The Department’s teachers were very flexible in developing an academic programme that meets the needs of URALCHEM. We are a young company focused on development, and we are pleased with the desire for self-improvement shown by our employees. Since the beginning of our cooperation with Moscow State University, 236 workers from URLACHEM’s enterprises have already completed the courses. Our cooperation with one of the best universities in the country is helping to raise the professional level of our own people and is at the same time increasing the overall prestige of the chemist’s profession.”
Igor Kotlobovsky, Vice Rector of Moscow State University said, “On behalf of Moscow University, I would like to thank URALCHEM for its support, which has allowed the Department of Chemistry to have state-of-the-art equipment installed in one of its halls. The room has been fully modernised, whilst preserving its historical facade and decorative ceiling mouldings. Classes can now even be held remotely, so, students such as URALCHEM’s employees will be able to be trained without leaving their workplace. The partnership between the university and URALCHEM shows how fruitful cooperation of science and business can be.”
Tel: +7 (495) 721 89 89
URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.
Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.